BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14739666)

  • 41. Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.
    Chamberlain MC; Johnston SK
    Cancer; 2009 Oct; 115(20):4775-82. PubMed ID: 19569246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin].
    Ribrag V; Droz JP; Bouleuc C; Theodore C; Ghosn M; Pico JL; Azab M; Ostronoff M; Hayat M
    Presse Med; 1990 Jul 7-14; 19(27):1263-6. PubMed ID: 2143824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
    Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
    Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors.
    Mayer F; Honecker F; Looijenga LH; Bokemeyer C
    Ann Oncol; 2003 Jun; 14(6):825-32. PubMed ID: 12796018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
    Kollmannsberger C; Beyer J; Droz JP; Harstrick A; Hartmann JT; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 1998 Oct; 16(10):3386-91. PubMed ID: 9779717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial.
    Motzer RJ; Dmitrovsky E; Miller WH; Tong WP; Bajorin DF; Scher HI; Bost GJ
    Cancer; 1993 Dec; 72(11):3313-7. PubMed ID: 8242558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC; Tsao-Wei DD
    Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.
    Christian JA; Huddart RA; Norman A; Mason M; Fossa S; Aass N; Nicholl EJ; Dearnaley DP; Horwich A
    J Clin Oncol; 2003 Mar; 21(5):871-7. PubMed ID: 12610187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human germ cell tumours: expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin.
    Hanigan MH; Frierson HF; Abeler VM; Kaern J; Taylor PT
    Br J Cancer; 1999 Sep; 81(1):75-9. PubMed ID: 10487615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
    Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.
    Fizazi K; Culine S; Droz JP; Kramar A; Théodore C; Ruffié P; Le Chevalier T
    J Clin Oncol; 1998 Feb; 16(2):725-32. PubMed ID: 9469363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma.
    Dervisis NG; Dominguez PA; Sarbu L; Newman RG; Cadile CD; Swanson CN; Kitchell BE
    J Am Vet Med Assoc; 2007 Aug; 231(4):563-9. PubMed ID: 17696856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mediastinal germ cell tumors. A continuing odyssey.
    Golbey RB
    Chest Surg Clin N Am; 1994 Feb; 4(1):195-200. PubMed ID: 7519959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cisplatin-based chemotherapy for testicular cancer in a patient with spinal muscular atrophy: a case report.
    Sokol DB; Hudes GR
    Am J Clin Oncol; 1998 Aug; 21(4):420-1. PubMed ID: 9708647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complete disappearance of multiple periorbital xanthelasmata after chemotherapy for primary extragonadal germ-cell mediastinal tumor.
    Eleftheriades D; Theofilopoulou M; Eleftheriades N; Vrizides P; Pistevou-Gompaki K
    Ann Oncol; 2004 Sep; 15(9):1445-6. PubMed ID: 15319255
    [No Abstract]   [Full Text] [Related]  

  • 59. Hematologic malignancies associated with primary mediastinal germ-cell tumors.
    Nichols CR; Hoffman R; Einhorn LH; Williams SD; Wheeler LA; Garnick MB
    Ann Intern Med; 1985 May; 102(5):603-9. PubMed ID: 2984971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation.
    Chin JL; Banerjee D; Kadhim SA; Kontozoglou TE; Chauvin PJ; Cherian MG
    Cancer; 1993 Nov; 72(10):3029-35. PubMed ID: 8221570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.